IP Verse

Antiparasitic Use Of Isoxazoline Compounds - EP3079474

The patent EP3079474 was granted to Intervet on Jul 3, 2019. The application was originally filed on Dec 9, 2014 under application number EP14809838A. The patent is currently recorded with a legal status of "Revoked".

EP3079474

INTERVET
Application Number
EP14809838A
Filing Date
Dec 9, 2014
Status
Revoked
Sep 19, 2024
Publication Date
Jul 3, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CEVA SANTE ANIMALEApr 3, 2020CABINET BECKER ASSOCIES -
CEVA SANTE ANIMALEApr 3, 2020CABINET BECKER ET ASSOCIES -
VIRBACApr 3, 2020GEVERS & ORES -

Patent Citations (24) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2007066617
DESCRIPTIONWO2005085216
DESCRIPTIONWO2007079162
DESCRIPTIONWO2009002809
DESCRIPTIONWO2009003075
DESCRIPTIONWO2009024541
DESCRIPTIONWO2009080250
DESCRIPTIONWO2010070068
DESCRIPTIONWO2010079077
DESCRIPTIONWO2013119442
DESCRIPTIONWO2013150052
DESCRIPTIONWO2013150055
INTERNATIONAL-SEARCH-REPORTEP1119256
INTERNATIONAL-SEARCH-REPORTWO2009024541
INTERNATIONAL-SEARCH-REPORTWO2013150055
OPPOSITIONEP1671941
OPPOSITIONEP1731512
OPPOSITIONEP2151437
OPPOSITIONWO2007079162
OPPOSITIONWO2009002809
OPPOSITIONWO2009003075
OPPOSITIONWO2009024541
OPPOSITIONWO2013119442
OPPOSITIONWO2013150055

Non-Patent Literature (NPL) Citations (23) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- "Classification (fleas)", Richard Wall et al, Veterinary Ectoparasites : Biology, Pathology and Control. 2nd ed., Blackwell Science, (20010000), pages 148 - 153, XP055732395
OPPOSITION- Ema, "Bravecto", ANNEXE I RÉSUMÉ DES CARACTÉRISTIQUES DU PRODUIT, (20140211), pages 1 - 57, URL: https://www.ema.europa.eu/en/documents/product-information/bravecto-epar-product-information_fr.pdf, XP055732279
OPPOSITION- EMA, "Bravecto", ANNEXE I RÉSUMÉ DES CARACTÉRISTIQUES DU PRODUIT, (20140211), pages 1 - 57, URL: https://www.ema.europa.eu/en/documents/product-information/bravecto-epar-product-information_fr.pdf, XP055732279
OPPOSITION- EMA, "CVMP assessment report for Bravecto", European Medicines Agency (EM EA/ V/C/002526/0000), (20131212), pages 1 - 22, URL: https://www.ema.europa.eu/en/documents/assessment-report/bravecto-epar-public-assessment-report_en.pdf, XP055733714
OPPOSITION- FDA, "NEXGARD", Freedom of Information Summary NADA 141-406, (20130914), pages 1 - 22, XP055733690
OPPOSITION- "Lesson 1 : Introduction to Pharmacokinetics and Pharmacodynamics", JOSEPH T. DIPIRO, Concepts in Clinical Pharmacokinetics. 5th ed., ASHP, (20100000), pages 1 - 18, XP055733602
OPPOSITION- URSO R et al., "A short introduction to pharmacokinetics", Eur Rev Med Pharmacol Sci., (20020300), vol. 6, no. 2-3, pages 33 - 44, XP055732403
OPPOSITION- WADE SE et al., "Survival and reproduction of artificially fed cat fleas, Ctenocephalides felis (Siphonaptera: Pulicidae)", J Med Entomol, (19880500), vol. 25, no. 3, pages 186 - 90, XP055732374
OPPOSITION- M. W. DRYDEN et al., "The cat flea: biology, ecology and control", Veterinary Parasitology, (19940000), vol. 52, doi:10.1016/0304-4017(94)90031-0, pages 1 - 19, XP023891494
OPPOSITION- OZOE Y et al., "The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels", Biochem Biophys Res Commun, (20091126), vol. 391, no. 1, doi:10.1016/j.bbrc.2009.11.131, pages 744 - 749, XP026907975
OPPOSITION- SHOOP W. L. et al., "Discovery and mode of action of afoxolaner, a new isoxazoline parasiticide for dogs", Veterinary Parasitology, (20140000), vol. 201, no. 3, pages 179 - 189, XP028843259
OPPOSITION- Letendre Laura et al, "The intravenous and oral pharmacokinetics of afoxolaner used as a monthly chewable antiparasitic for dogs", Veterinary Parasitology, (20140401), vol. 201, no. 3, pages 190 - 197, XP028843260
OPPOSITION- BRUCE N. KUNKLE et al., "Assessment of the onset of action of afoxolaner against existing adult flea (Ctenocephalides felis) infestations on dogs", Veterinary Parasitology, (20140402), vol. 201, no. 3-4, pages 204 - 211, XP028843262
OPPOSITION- JAMES S. HUNTER et al., "Evaluation of the curative and preventive efficacy of a single oral administration of afoxolaner against cat flea Ctenocephalides felis infestations on dogs", Veterinary Parasitology, (2014), vol. 201, no. 3, pages 207 - 211, XP028843263
OPPOSITION- GARCÍA-REYNAGA P et al., "New GABA/glutamate receptor target for [3H]isoxazoline insecticide", Chem Res Toxicol., (20130312), vol. 26, no. 4, pages 514 - 516, XP055732408
OPPOSITION- DIDIER N. et al., "Therapy, control and prevention of flea allergy dermatitis in dogs and cats", Veterinary Dermatology, (20011225), vol. 11, no. 2, pages 83 - 98, XP055732397
OPPOSITION- M. W. DRYDEN, "Flea and tick control in the 21 st century: challenges and opportunities", VETERINARY DERMATOLOGY, (20091001), vol. 20, no. 5-6, pages 435 - 440, XP055243773
OPPOSITION- WILLIAMS H et al., "Fluralane, a novel isoxazoline, prevents flea (Ctenocephalides felis) reproduction in vitro and in a simulated home environment", Parasit Vectors, (20140619), vol. 7, no. 1, page 275, XP021189692
OPPOSITION- WALTHER et al., "The effect of food on the pharmacokinetics of oral fluralaner in dogs", Parasites & Vectors, (20140305), vol. 7, no. 1, doi:10.1186/1756-3305-7-84, page 84, XP021179156
OPPOSITION- KILP et al., "Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration", Parasites & Vectors, (20140307), vol. 7, no. 1, page 85, XP021179157
OPPOSITION- SUSANNE KILP et al., "Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration", Parasit Vectors, (20140307), vol. 7, doi:10.1186/1756-3305-7-85, page 85, XP021179157
OPPOSITION- Janina Taenzler et al, "Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs", Parasites & Vectors, (20141204), vol. 7, no. 1, page 567, XP021206537
OPPOSITION- M. FRANC, "Puces et méthodes de lutte", Rev. sci. tech. Off int. Epiz., (19941201), vol. 13, no. 4, pages 1019 - 1037, XP055732375

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents